NCT05969106View on ClinicalTrials.gov

Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics

CompletedOBSERVATIONAL
Enrollment

84

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Type 1 Diabetes
Interventions
DEVICE

Tandem Control-IQ

AID-system

Trial Locations (1)

43480

The hospital of Halland Kungsbacka, Kungsbacka

All Listed Sponsors
lead

Vastra Gotaland Region

OTHER_GOV

NCT05969106 - Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics | Biotech Hunter | Biotech Hunter